Intensive blood pressure (BP) control targeting <130/80 mm Hg reduced cardiovascular events and mortality consistently across all baseline diastolic blood pressure (DBP) strata in a post hoc analysis of 33,288 participants from the China Rural Hypertension Control Project, with no evidence that lower DBP diminished benefit. Participants were categorized into quartiles of baseline DBP (≤80.7, 80.7–87.3, 87.3–94.3, and >94.3 mm Hg), and compared with usual care, intensive management led to substantial risk reductions in cardiovascular outcomes in every group, with adjusted hazard ratios ranging from 0.59 to 0.69 and a non-significant interaction between treatment effect and DBP level. Although intensive treatment increased the risk of hypotension across DBP categories, it did not raise the incidence of injurious falls, syncope, or adverse kidney outcomes. Delivered by non-physician providers, this intervention demonstrates that intensive BP lowering is broadly effective and safe even among individuals with lower baseline DBP, supporting its application in real-world high BP populations. A J-curve relationship between DBP and CVD events has been proposed. However, evidence from Mendelian randomization studies refuted the J-shaped association and established a linear correlation between DBP and CVD. Source: https://heart.bmj.com/
A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…
Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…
A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…
Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…
A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…
Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…
This website uses cookies.